COMT, neuropsychological function and brain structure in schizophrenia: A systematic review and neurobiological interpretation

Journal of Psychiatry and Neuroscience

Volumn 38, Issue 6, 2013, Pages 366-380

  Ira, Elisa ^a   Zanoni, Martina ^a   Ruggeri, Mirella ^a   Dazzan, Paola ^b   Tosato, Sarah ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ANATOMICAL CONCEPTS; COGNITION; CONTINUOUS PERFORMANCE TEST; ENDOPHENOTYPE; FRONTAL LOBE; GENETIC POLYMORPHISM; HERITABILITY; HUMAN; N BACK TASK; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TASK PERFORMANCE; TEMPORAL LOBE; WISCONSIN CARD SORTING TEST;

ATROPHY; BRAIN; CATECHOL O-METHYLTRANSFERASE; ENDOPHENOTYPES; FRONTAL LOBE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TEMPORAL LOBE;

EID: 84886671321     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.120178     Document Type: Review

References (151)

1. Bilder RM. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002;52: 701-7.
2. Tosato S, Bonetto C, Di Forti M, et al. Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients. Neurosci Lett 2011;495:17-21.
3. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003;160:469-76.
4. Fan JB, Zhang CS, Gu NF, et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 2005; 57:139-44.
5. Munafò MR, Bowes L, Clark TG, et al. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 2005;10:765-70.
6. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008;40:827-34.
7. Meisenzahl EM, Schmitt GJ, Scheuerecker J, et al. The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry 2007;19:337-45.
8. Antonova E, Kumari V, Morris R, et al. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol Psychiatry 2005;58:457-67.
9. Ehrlich S, Morrow EM, Roffman JL, et al. The COMT Val108/158Met polymorphism and medial temporal lobe volu met-ry in patients with schizophrenia and healthy adults. Neuroimage 2010;53:992-1000.
10. McIntosh AM, Baig BJ, Hall J, et al. Relationship of catechol-Omethyltransferase variants to brain structure and function in a popu lation at high risk of psychosis. Biol Psychiatry 2007;61:1127-34.
11. Ohnishi T, Hashimoto R, Mori T, et al. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006;129:399-410.
12. Allen AJ. Endophenotypes in schizophrenia: a selective review. Schizophr Res 2009;109:24-37.
13. Prasad KM, Keshavan MS. Structural cerebral variations as useful endophenotypes in schizophrenia: Do they help construct "extended endophenotypes"? Schizophr Bull 2008;34:774-90.
14. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-45.
15. Mazzoncini R, Zoli M, Tosato S, et al. Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour? World J Biol Psychiatry 2009;10:778-97.
16. Green AE, Kraemer DJ, Deyoung CG, et al. A gene-brain-cognition pathway: prefrontal activity mediates the effect of COMT on cognitive control and IQ. Cereb Cortex 2012 Feb. 24. [Epub ahead of print]
17. Gong P, Zhang H, Chi W, et al. An association study on the polymorphisms of dopaminergic genes with working memory in a healthy Chinese Han population. Cell Mol Neurobiol 2012;32:1011-9.
18. Blanchard MM, Blanchard MM, Chamberlain SR, et al. Effects of two dopamine-modulating genes (DAT1 9/10 and COMT Val/Met) on n-back working memory performance in healthy volunteers. Psychol Med 2011;41:611-8.
19. Greenwood K, Hung CF, Tropeano M, et al. No association between the catechol-O-methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia. Neurosci Lett 2011;496:65-9.
20. Wishart HA, Roth RM, Saykin AJ, et al. COMT Val158Met genotype and individual differences in executive function in healthy adults. J Int Neuropsychol Soc 2011;17:174-80.
21. Stokes PR, Rhodes RA, Grasby PM, et al. The effects of the COMT Val108/158Met polymorphism on BOLD activation during working memory, planning, and response inhibition: A role for the posterior cingulate cortex? Neuropsychopharmacology 2011;36:763-71.
22. Rosa EC, Dickinson D, Apud J, et al. COMT Val158Met polymorphism, cognitive stability and cognitive flexibility: an experimental examination. Behav Brain Funct 2010;6:53.
23. Solís-Ortiz S, Perez-Luque E, Morado-Crespo L, et al. Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-omethyltransferase gene: a behavioral genetic study. Behav Brain Funct 2010;6:67.
24. Uçok A, Ozturk M, Duman Z, et al. COMT Val 158 Met polymorphism is related with interpersonal problem solving in schizophrenia. Eur Psychiatry 2010;25:320-2.
25. Wilkosc M, Hauser J, Tomaszewska M, et al. Influence of dopa-minergic and serotoninergic genes on working memory in healthy subjects. Acta Neurobiol Exp (Warsz) 2010;70:86-94.
26. Wirgenes KV, Djurovic S, Sundet K, et al. Catechol O-methyltransferase variants and cognitive performance in schizophrenia and bipolar disorder versus controls. Schizophr Res 2010;122:31-7.
27. Pomarol-Clotet E, Fatjo-Vilas M, McKenna PJ, et al. COMT Val158Met polymorphism in relation to activation and deactivation in the prefrontal cortex: A study in patients with schizophrenia and healthy subjects. Neuroimage 2010;53:899-907.
28. Dennis NA, Need AC, LaBar KS, et al. COMT val108/158 met genotype affects neural but not cognitive processing in healthy individuals. Cereb Cortex 2010;20:672-83.
29. van den Bos R, Homberg J, Gijsbers E, et al. The effect of COMT Val158 Met genotype on decision-making and preliminary findings on its interaction with the 5-HTTLPR in healthy females. Neuropharmacology 2009;56:493-8.
30. Yue C, Wu T, Deng W, et al. Comparison of visual evoked-related potentials in healthy young adults of different catechol-O-methyltransferase genotypes in a continuous 3-back task. Neuroreport 2009;20:521-4.
31. Krug A, Markov V, Sheldrick A, et al. The effect of the COMT val(158)met polymorphism on neural correlates of semantic verbal fluency. Eur Arch Psychiatry Clin Neurosci 2009;259:459-65.
32. Neuhaus AH, Opgen-Rhein C, Urbanek C, et al. COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia. Pharmacopsychiatry 2009;42:141-4.
33. Prata DP, Mechelli A, Fu CH, et al. Opposite effects of catechol-Omethyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol Psychiatry 2009;65:473-80.
34. Schmack K, Schlagenhauf F, Sterzer P, et al. Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage 2008;42:1631-8.
35. Sheldrick AJ, Krug A, Markov V, et al. Effect of COMT val158met genotype on cognition and personality. Eur Psychiatry 2008;23:385-9.
36. Roussos P, Giakoumaki SG, Pavlakis S, et al. Planning, decisionmaking and the COMT rs4818 polymorphism in healthy males. Neuropsychologia 2008;46:757-63.
37. Roffman JL, Weiss AP, Deckersbach T, et al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:990-5.
38. Opgen-Rhein C, Neuhaus AH, Urbanek C, et al. Executive attention in schizophrenic males and the impact of COMT Val108 /158Met genotype on performance on the attention network test. Schizophr Bull 2008;34:1231-9.
39. Mata I, Perez-Iglesias R, Pelayo-Teran JM, et al. Lack of influence of COMT Val158Met genotype on cognition in first-episode nonaffective psychosis. Schizophr Res 2008;102:206-9.
40. Diaz-Asper CM, Goldberg TE, Kolachana BS, et al. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol Psychiatry 2008;63:72-9.
41. Bertolino A, Di Giorgio A, Blasi G, et al. Epistasis between dopamine regulating genes identifies a nonlinear response of the human hippocampus during memory tasks. Biol Psychiatry 2008; 64:226-34.
42. Aguilera M, Barrantes-Vidal N, Arias B, et al. Putative role of the COMT gene polymorphism (Val158Met) on verbal working memory functioning in a healthy population. Am J Med Genet B Neuro psychiatr Genet 2008;147B:898-902.
43. Woodward ND, Jayathilake K, Meltzer HY. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Schizophr Res 2007;90:86-96.
44. MacDonald AW III, Carter CS, Flory JD, et al. COMT Val158Met and executive control: a test of the benefit of specific deficits to translational research. J Abnorm Psychol 2007;116:306-12.
45. Ehlis AC, Reif A, Herrmann MJ, et al. Impact of catechol-Omethyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 2007;32:162-70.
46. Dickerson FB, Boronow JJ, Stallings C, et al. The catechol-Omethyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia. Schizophr Res 2007;96:87-92.
47. Caldú X, Vendrell P, Bartres-Faz D, et al. Impact of the COMT Val108 /158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 2007;37:1437-44.
48. Barnett JH, Jones PB, Robbins TW, et al. Effects of the catechol-Omethyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 2007;12:502-9.
49. Szöke A, Schürhoff F, Méary A, et al. Lack of influence of COMT and NET genes variants on executive functions in schizophrenic and bipolar patients, their first-degree relatives and controls. Am J Med Genet B Neuropsychiatr Genet 2006;141B:504-12.
50. Rybakowski JK, Borkowska A, Czerski PM, et al. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET). Psychiatry Res 2006; 143:13-9.
51. Krabbendam L, Isusi P, Galdos P, et al. Associations between COMTVal158Met polymorphism and cognition: Direct or indirect effects? Eur Psychiatry 2006;21:338-42.
52. Han DH, Kee BS, Min KJ, et al. Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 2006; 17:95-9.
53. Golimbet V, Gritsenko I, Alfimova M, et al. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J Biol Psychiatry 2006;7:238-45.
54. Bertolino A, Rubino V, Sambataro F, et al. Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biol Psychiatry 2006;60:1250-8.
55. Stefanis NC, van Os J, Avramopoulos D, et al. Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: tuning rather than improving performance. Am J Psychiatry 2005;162:1752-4.
56. Ho BC, Wassink TH, O'Leary DS, et al. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 2005;10:229, 287-98.
57. Galderisi S, Maj M, Kirkpatrick B, et al. COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. Schizophr Res 2005;73:27-30.
58. Bruder GE, Keilp JG, Xu H, et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry 2005;58:901-7.
59. Blasi G, Mattay VS, Bertolino A, et al. Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci 2005;25:5038-45.
60. Rosa A, Peralta V, Cuesta MJ, et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 2004;161:1110-2.
61. Nolan KA, Bilder RM, Lachman HM, et al. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 2004;161:359-61.
62. de Frias CM, Annerbrink K, Westberg L, et al. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet 2004;34:533-9.
63. Tsai SJ, Yu YW, Chen TJ, et al. Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 2003;338:123-6.
64. Goldberg TE, Egan MF, Gscheidle T, et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003; 60: 889-96.
65. Malhotra AK, Kestler LJ, Mazzanti C, et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002;159:652-4.
66. Joober R, Gauthier J, Lal S, et al. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 2002;59:662-3.
67. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 2001;98:6917-22.
68. Bellani M, Brambilla P. The use and meaning of the continuous performance test in schizophrenia. Epidemiol Psichiatr Soc 2008;17: 188-91.
69. Uçok A, Ozturk M, Duman Z, et al. COMT Val 158 Met polymorphism is related with interpersonal problem solving in schizophrenia. Eur Psychiatry 2010;25:320-2.
70. Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 2006;16:17-42.
71. Mahurin RK, Velligan DI, Hazleton B, et al. Trail making test errors and executive function in schizophrenia and depression. Clin Neuro psychol 2006;20:271-88.
72. Sánchez-Cubillo I, Perianez JA, Drover-Roig D, et al. Construct valid ity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc 2009;15:438-50.
73. Burdick KE, Funke B, Goldberg JF, et al. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord 2007;9:370-6.
74. O'Hara R, Miller E, Liao CP, et al. COMT genotype, gender and cognition in community-dwelling, older adults. Neurosci Lett 2006; 409: 205-9.
75. Winterer G, Musso F, Vucurevic G, et al. COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits. Neuro image 2006;32:1722-32.
76. Barnes A, Isohanni M, Barnett JH, et al. No association of COMT (Val158Met) genotype with brain structure differences between men and women. PLoS ONE 2012;7:e33964.
77. Cerasa A, Cherubini A, Quattrone A, et al. Met158 variant of the catechol-O-methyltransferase genotype is associated with thicker cortex in adult brain. Neuroscience 2010;167:809-14.
78. Honea R, Verchinski BA, Pezawas L, et al. Impact of interacting functional variants in COMT on regional gray matter volume in human brain. Neuroimage 2009;45:44-51.
79. Dutt A, McDonald C, Dempster E, et al. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychol Med 2009;39:1783-97.
80. Zinkstok J, Schmitz N, van Amelsvoort T, et al. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes Brain Behav 2008;7:61-9.
81. Cerasa A, Gioia MC, Labate A, et al. Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume. Neuroreport 2008;19:405-8.
82. Taylor WD, Zuchner S, Payne ME, et al. The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults. Psychiatry Res 2007;155:173-7.
83. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, et al. Lowactivity allele of catechol-O-methyltransferase (COMTL) is associated with increased lateral ventricles in patients with first episode non-affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1514-8.
84. Zinkstok J, Schmitz N, van Amelsvoort T, et al. The COMT val158met polymorphism and brain morphometry in healthy young adults. Neurosci Lett 2006;405:34-9.
85. Krach S, Jansen A, Krug A, et al. COMT genotype and its role on hippocampal-prefrontal regions in declarative memory. Neuro image 2010;53:978-84.
86. Di Giorgio A, Caforio G, Blasi G, et al. Catechol-O-methyltransferase Val(158)Met association with parahippocampal physiology during memory encoding in schizophrenia. Psychol Med 2011;41:1721-31.
87. Mier D, Kirsch P, Meyer-Lindenberg A. Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2010;15:918-27.
88. Karch S, Leicht G, Giegling I, et al. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task. J Psychiatr Res 2009;43:1185-94.
89. Blokland GA, McMahon KL, Hoffman J, et al. Quantifying the herit ability of task-related brain activation and performance during the N-back working memory task: a twin fMRI study. Biol Psychol 2008;79:70-9.
90. Daban C, Amado I, Bourdel MC, et al. Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res 2005;39:391-8.
91. Elsabagh S, Premkumar P, Anilkumar AP, et al. A longer duration of schizophrenic illness has sex-specific associations within the working memory neural network in schizophrenia. Behav Brain Res 2009;201:41-7.
92. Krieger S, Lis S, Janik H, et al. Executive function and cognitive subprocesses in first-episode, drug-naive schizophrenia: an analysis of N-back performance. Am J Psychiatry 2005;162:1206-8.
93. Bove EA. Cognitive performance and basic symptoms in first-degree relatives of schizophrenic patients. Compr Psychiatry 2008;49:321-9.
94. Zilles D, Burke S, Schneider-Axmann T, et al. Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2009;259:309-15.
95. Callicott JH, Egan MF, Mattay VS, et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 2003;160:709-19.
96. Scala S, Lasalvia A, Cristofalo D, et al. Neurocognitive profile and its association with psychopathology in first-degree relatives of patients with schizophrenia. A case-control study. Psychiatry Res 2012; 200: 137-43.
97. Saoud M, d'Amato T, Gutknecht C, et al. Neuropsychological deficit in siblings discordant for schizophrenia. Schizophr Bull 2000; 26:893-902.
98. Wang Q, Chan R, Sun J, et al. Reaction time of the Continuous Performance Test is an endophenotypic marker for schizophrenia: a study of first-episode neuroleptic-naive schizophrenia, their nonpsychotic first-degree relatives and healthy population controls. Schizophr Res 2007;89:293-8.
99. Cornblatt BA, Risch NJ, Faris G, et al. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res 1988;26:223-38.
100. Chen WJ, Hsiao CK, Hsiao LL, et al. Performance of the Continuous Performance Test among community samples. Schizophr Bull 1998;24:163-74.
101. Cornblatt BA, Malhotra AK. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet 2001;105:11-5.
102. Cornblatt B, Obuchowski M, Roberts S, et al. Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol 1999;11:487-508.
103. Tsuang HC, Lin SH, Liu SK, et al. More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia fam-ilies than in those of simplex ones. Schizophr Res 2006;87:172-80.
104. Ellison-Wright I, Glahn DC, Laird AR, et al. The anatomy of firstepisode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008;165:1015-23.
105. Fornito A, Yucel M, Patti J, et al. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 2009;108:104-13.
106. Glahn DC, Laird AR, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008;64:774-81.
107. Shepherd AM, Laurens KR, Matheson SL, et al. Systematic metareview and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 2012;36:1342-56.
108. Steen RG, Mull C, McClure R, et al. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 2006;188:510-8.
109. Vita A, De PL, Silenzi C, et al. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 2006;82:75-88.
110. Wright IC, Rabe-Hesketh S, Woodruff PW, et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000;157:16-25.
111. Peper JS, Brouwer RM, Boomsma DI, et al. Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Mapp 2007;28:464-73.
112. Adriano F, Caltagirone C, Spalletta G. Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and metaanalysis. Neuroscientist 2012;18:180-200.
113. Boos HB, Aleman A, Cahn W, et al. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry 2007; 64:297-304.
114. Seidman LJ, Faraone SV, Goldstein JM, et al. Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic res-onance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry 2002;59:839-49.
115. Baiano M, David A, Versace A, et al. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophr Res 2007;93:1-12.
116. Cannon TD, Thompson PM, van Erp TG, et al. Mapping heritability and molecular genetic associations with cortical features using probabilistic brain atlases: methods and applications to schizophrenia. Neuroinformatics 2006;4:5-19.
117. Fusar-Poli P, Borgwardt S, Crescini A, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev 2011;35:1175-85.
118. Smieskova R, Fusar-Poli P, Allen P, et al. Neuroimaging predictors of transition to psychosis-a systematic review and meta-analysis. Neurosci Biobehav Rev 2010;34:1207-22.
119. Dazzan P, Soulsby B, Mechelli A, et al. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull 2012;38:1083-91.
120. Ho BC. MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms. Schizophr Res 2007;96:1-13.
121. Job DE, Whalley HC, McConnell S, et al. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr Res 2003;64:1-13.
122. Cannon TD, Thompson PM, van Erp TG, et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci U S A 2002;99:3228-33.
123. McIntosh AM, Job DE, Moorhead WJ, et al. Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure. Am J Med Genet B Neuropsychiatr Genet 2006;141B:76-83.
124. Honea RA, Meyer-Lindenberg A, Hobbs KB, et al. Is gray matter volume an intermediate phenotype for schizophrenia? A voxelbased morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry 2008;63:465-74.
125. Goldman AL, Pezawas L, Mattay VS, et al. Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Biol Psychiatry 2008; 63:475-83.
126. Callicott JH, Bertolino A, Mattay VS, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000;10:1078-92.
127. Meyer-Lindenberg A, Poline JB, Kohn PD, et al. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 2001;158:1809-17.
128. Minzenberg MJ, Laird AR, Thelen S, et al. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry 2009;66:811-22.
129. Nejad AB, Ebdrup BH, Siebner HR, et al. Impaired temporoparietal deactivation with working memory load in antipsychotic-naive patients with first-episode schizophrenia. World J Biol Psychiatry 2011;12:271-81.
130. Piras F, Caltagirone C, Spalletta G. Working memory performance and thalamus microstructure in healthy subjects. Neuroscience 2010; 171:496-505.
131. Molina V, Solera S, Sanz J, et al. Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia. Psychiatry Res 2009;173:88-93.
132. Garlinghouse MA, Roth RM, Isquith PK, et al. Subjective rating of working memory is associated with frontal lobe volume in schizophrenia. Schizophr Res 2010;120:71-5.
133. Tsuchida A, Fellows LK. Lesion evidence that two distinct regions within prefrontal cortex are critical for n-back performance in humans. J Cogn Neurosci 2009;21:2263-75.
134. Salgado-Pineda P, Baeza I, Perez-Gomez M, et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 2003;19:365-75.
135. Laywer G, Nyman H, Agartz I, et al. Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression. BMC Psychiatry 2006;6:31.
136. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, et al. Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers. Schizophr Res 2009;115:191-201.
137. Goldberg TE, Torrey EF, Berman KF, et al. Relations between neuro psychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizo phrenia. Psychiatry Res 1994;55:51-61.
138. Volz H, Gaser C, Hager F, et al. Decreased frontal activation in schizophrenics during stimulation with the continuous perform-ance test-a functional magnetic resonance imaging study. Eur Psychiatry 1999;14:17-24.
139. Honey GD, Pomarol-Clotet E, Corlett PR, et al. Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function. Brain 2005;128:2597-611.
140. Yoon JH, Minzenberg MJ, Ursu S, et al. Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry 2008;165: 1006-14.
141. Delawalla Z, Csernansky JG, Barch DM. Prefrontal cortex function in nonpsychotic siblings of individuals with schizophrenia. Biol Psy chiatry 2008;63:490-7.
142. Perlstein WM, Dixit NK, Carter CS, et al. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry 2003;53:25-38.
143. Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis of the etiology of schizophrenia. Neuroscience 1991;41:1-24.
144. Cohen JD, Braver TS, Brown JW. Computational perspectives on dopamine function in prefrontal cortex. Curr Opin Neurobiol 2002;12: 223-9.
145. Bilder RM, Volavka J, Lachman HM, et al. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 2004;29:1943-61.
146. Dickinson D, Elvevåg B. Genes, cognition and brain through a COMT lens. Neuroscience 2009;164:72-87.
147. Tan HY, Callicott JH, Weinberger DR. Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cogn Neuropsychiatry 2009;14:277-98.
148. Tan HY, Nicodemus KK, Chen Q, et al. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J Clin Invest 2008;118:2200-8.
149. Russo SJ, Bolanos CA, Theobald DE, et al. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 2007;10:93-9.
150. Tan HY, Chen AG, Kolachana B, et al. Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment. Brain 2012; 135:1436-45.
151. Buckert M, Kudielka BM, Reuter M, et al. The COMT Val158Met polymorphism modulates working memory performance under acute stress. Psychoneuroendocrinology 2012;37:1810-21.